The $260M contract is transformative if deployed on schedule — monitor Q3 2026 for revenue ramp. The $4B pipeline and $1B annual target suggest potential for additional contracts. Key risks: ATH token price volatility ($20.2M at risk), hardware supply chain delays, and Nasdaq listing compliance. The stock is a high-risk/high-reward story stock — position sizing is critical.
Price Chart
Executive Summary
AGPU reported Q1 2026 revenue of $35K (down 68% YoY) and a net loss of $7.7M ($0.36/share), driven by $4.3M in non-cash mark-to-market losses on digital assets. The headline EPS of -$5.10 vs consensus is a massive miss, but the company signed a $260M enterprise contract in April 2026 (36-month take-or-pay for 2,304 NVIDIA B300 GPUs) that is expected to generate ~$21M/quarter in revenue starting Q3 2026, and management's pipeline exceeds $4B. The stock is a pre-revenue story stock with a $31M market cap — the EPS miss is mechanical (share count effects) and irrelevant; the bull case rests entirely on the $260M contract and $4B pipeline.
Key Financial Metrics
Key Facts
- Q1 2026 revenue $35K vs $110K YoY; net loss $7.7M ($0.36/share) vs $2.4M loss YoY
- EPS of -$5.10 vs consensus N/A — but GAAP EPS includes 14.7M pre-funded warrants in share count, making per-share metrics uninformative
- Signed $260M 36-month take-or-pay contract in April 2026 for 2,304 NVIDIA B300 GPUs; deployment targeted Q3 2026 with ~$21M/quarter revenue
- Pipeline exceeds $4B; management targeting $1B in new customer agreements by end of 2026
- Combined liquidity ~$36.5M ($6.9M cash + $20.2M ATH tokens + $9.4M current digital asset receivable)
- Compute Services revenue commenced in Q1 2026 ($7K); contract liabilities grew to $645K from customer prepayments
- Appointed Kyle Okamoto as President and Jeremy Yaukey-Witter as CFO
- Strategic alternatives review ongoing for legacy Drug Discovery Services (Helomics) business
Financial Impact
$260M contract → ~$21M/quarter revenue starting Q3 2026; current cash burn ~$3.7M/quarter; liquidity $36.5M sufficient through FY2026
Risk Factors
- ATH token price volatility could impair liquidity and balance sheet
- Hardware supply chain constraints could delay $260M cluster deployment beyond Q3 2026
- Nasdaq listing compliance risk (sub-$1 bid price or other continued listing standards)
- Customer performance risk on $260M take-or-pay contract
- Pre-funded warrant dilution overhang (14.7M warrants outstanding)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296182 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 5, 2026 21d ago | 8-K | $12.99 | awaiting T+20 | — | $7.99 (−38.49%) |
Oct 5, 2026 21d ago | Press Release | $12.99 | awaiting T+20 | — | $7.99 (−38.49%) |
Sep 9, 2026 6w ago | Insider Buy | $10.56 $11.41 | ▲ +8.05% | ▲ +5.67% | $7.99 (−24.34%) |
Aug 18, 2026 9w ago | Press Release | $10.33 $11.71 | ▲ +13.36% | ▲ +14.35% | $7.99 (−22.65%) |
Aug 17, 2026 10w ago | 8-K | $10.62 $11.06 | ▲ +4.10% | ▲ +6.07% | $7.99 (−24.76%) |
Aug 14, 2026 10w ago | Press Release | $10.62 $11.06 | ▲ +4.10% | ▲ +6.07% | $7.99 (−24.76%) |
Jul 27, 2026 13w ago | 8-K | $7.21 $10.27 | ▲ +42.44% | ▲ +39.14% | $7.99 (+10.82%) |
Jul 22, 2026 13w ago | 8-K | $7.11 $10.90 | ▲ +53.31% | ▲ +50.41% | $7.99 (+12.38%) |
Jul 20, 2026 13w ago | S-3/A | $9.54 $10.33 | ▼ −8.28% | ▼ −5.72% | $7.99 (+16.25%) |
Jul 2, 2026 16w ago | S-3/A | $7.08 $8.50 | ▼ −20.06% | ▼ −20.47% | $7.99 (−12.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers